Key result
Testicular cancer survivorship is linked to ~13-point higher plaque rate, driven by metabolic risk factors.
Why the study?
Cardiovascular disease risk is increased in survivors of testicular cancer due to treatment exposure and lifestyle changes, but the association with subclinical arteriosclerosis is unclear.
Case-Control (n=103)
No
Warrants attention to metabolic risks in testicular cancer survivors; leaves open any direct chemotherapy effect on atherosclerosis.
Cardiovascular disease risk is increased in survivors of testicular cancer because of exposure to treatment (chemotherapy and radiotherapy), as well as modification in lifestyle. Our aim was to assess the presence of subclinical arteriosclerosis in survivors of testicular cancer in comparison with a control group. This was a cross-sectional, observational, case–control study including 50 survivors of Germ Cell Tumor (GCT) (14 years of follow-up) and 53 age-matched controls with no cancer. We registered clinical data, cardiovascular risk factors, physical and Mediterranean questionnaires, intima-media thickness and plaque at carotid and femoral arteries by ultrasound, calcium score at the abdominal aorta, and liver steatosis by computed tomography, and applied analytical tests to quantify metabolic risk factors and inflammation markers. Patients showed a trend toward greater intima-media thickness (IMT) and plaques than controls, as well as a higher calcium score in the abdominal aorta. Remarkably, patients had higher waist circumference, insulin resistance (HOMA-IR), and liver steatosis, but lower physical activity and high-density lipoprotein (HDL) cholesterol than controls (all p < 0.05). In multivariate analyses, only common vascular risk factors were associated with subclinical arteriosclerosis. As a conclusion, in our study, a higher rate of subclinical arteriosclerosis in testicular cancer survivors was associated with classical metabolic risk factors and lifestyle, but not with exposure to chemotherapy.
No takes yet. Share an insight, caveat, or question.
Espíldora-Hernández et al. (2020) conducted a case-control in Testicular Cancer (n=103). History of testicular cancer treated with chemotherapy vs. Healthy age-matched men was evaluated on Total subclinical arteriosclerotic plaques identified in investigated arterial territories (p=<0.05). Long-term survivors of testicular cancer exhibited a significantly higher rate of total arteriosclerotic plaques (28% vs 15%) compared to age-matched controls, though this was associated with classical metabolic risk factors and lifestyle rather than chemotherapy exposure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: